African American patients may or may not have poorer response rates after monoclonal antibody treatment: Overreliance on P values in underpowered studies

Mark A. Fiala

doi:10.1002/cncr.32082

African American patients may or may not have poorer response rates after monoclonal antibody treatment: Overreliance on P values in underpowered studies

Mark A. Fiala

Institute of Clinical and Translational Sciences (ICTS)

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	2321-2322
Number of pages	2
Journal	Cancer
Volume	125
Issue number	13
DOIs	https://doi.org/10.1002/cncr.32082
State	Published - Jul 1 2019

Access to Document

10.1002/cncr.32082

Cite this

@article{d39b99a0374b48bcb9c64dbfb9523968,

title = "African American patients may or may not have poorer response rates after monoclonal antibody treatment: Overreliance on P values in underpowered studies",

author = "Fiala, \{Mark A.\}",

year = "2019",

month = jul,

day = "1",

doi = "10.1002/cncr.32082",

language = "English",

volume = "125",

pages = "2321--2322",

journal = "Cancer",

issn = "0008-543X",

number = "13",

}

TY - JOUR

T1 - African American patients may or may not have poorer response rates after monoclonal antibody treatment

T2 - Overreliance on P values in underpowered studies

AU - Fiala, Mark A.

PY - 2019/7/1

Y1 - 2019/7/1

UR - https://www.scopus.com/pages/publications/85063590430

U2 - 10.1002/cncr.32082

DO - 10.1002/cncr.32082

M3 - Letter

C2 - 30919445

AN - SCOPUS:85063590430

SN - 0008-543X

VL - 125

SP - 2321

EP - 2322

JO - Cancer

JF - Cancer

IS - 13

ER -

African American patients may or may not have poorer response rates after monoclonal antibody treatment: Overreliance on P values in underpowered studies

Access to Document

Other files and links

Cite this